Modulation of mesenteric collecting lymphatic contractions by σ1-receptor activation and nitric oxide production

Am J Physiol Heart Circ Physiol. 2017 Oct 1;313(4):H839-H853. doi: 10.1152/ajpheart.00702.2016. Epub 2017 Aug 4.

Abstract

Recently, it has been reported that a σ-receptor antagonist could reduce inflammation-induced edema. Lymphatic vessels play an essential role in removing excess interstitial fluid. We tested the hypothesis that activation of σ-receptors would reduce or weaken collecting lymphatic contractions. We used isolated, cannulated rat mesenteric collecting lymphatic vessels to study contractions in response to the σ-receptor agonist afobazole in the absence and presence of different σ-receptor antagonists. We used RT-PCR and Western blot analysis to investigate whether these vessels express the σ1-receptor and immunofluorescence confocal microscopy to examine localization of the σ1-receptor in the collecting lymphatic wall. Using N-nitro-l-arginine methyl ester (l-NAME) pretreatment before afobazole in isolated lymphatics, we tested the role of nitric oxide (NO) signaling. Finally, we used 4-amino-5-methylamino-2',7'-difluorofluorescein diacetate fluorescence as an indicator to test whether afobazole increases NO release in cultured lymphatic endothelial cells. Our results show that afobazole (50-150 µM) elevated end-systolic diameter and generally reduced pump efficiency and that this response could be partially blocked by the σ1-receptor antagonists BD 1047 and BD 1063 but not by the σ2-receptor antagonist SM-21. σ1-Receptor mRNA and protein were detected in lysates from isolated rat mesenteric collecting lymphatics. Confocal images with anti-σ1-receptor antibody labeling suggested localization in the lymphatic endothelium. Blockade of NO synthases with l-NAME inhibited the effects of afobazole. Finally, afobazole elicited increases in NO production from cultured lymphatic endothelial cells. Our findings suggest that the σ1-receptor limits collecting lymphatic pumping through a NO-dependent mechanism.NEW & NOTEWORTHY Relatively little is known about the mechanisms that govern contractions of lymphatic vessels. σ1-Receptor activation has been shown to reduce the fractional pump flow of isolated rat mesenteric collecting lymphatics. The σ1-receptor was localized mainly in the endothelium, and blockade of nitric oxide synthase inhibited the effects of afobazole.

Keywords: afobazole; collecting lymphatic; lymphatic endothelium; nitric oxide; σ1-receptor.

MeSH terms

  • Animals
  • Benzimidazoles / pharmacology
  • Cells, Cultured
  • Endothelial Cells / drug effects
  • Endothelial Cells / metabolism
  • Enzyme Inhibitors / pharmacology
  • Lymphatic Vessels / drug effects*
  • Lymphatic Vessels / metabolism*
  • Male
  • Mesentery / drug effects*
  • Mesentery / metabolism*
  • Morpholines / pharmacology
  • Muscle Contraction / drug effects
  • Muscle, Smooth, Vascular / drug effects
  • NG-Nitroarginine Methyl Ester / pharmacology
  • Nitric Oxide / biosynthesis*
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, Opioid, delta / agonists*
  • Receptors, Opioid, delta / antagonists & inhibitors

Substances

  • 2-((2-morpholino)ethylthio)-5-ethoxybenzimidazole
  • Benzimidazoles
  • Enzyme Inhibitors
  • Morpholines
  • Oprd1 protein, rat
  • Receptors, Opioid, delta
  • Nitric Oxide
  • NG-Nitroarginine Methyl Ester